$GENB
Generate Biomedicines, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Somerville, MA
GENB chart
What traders are saying about $GENB
Latest postsGenerate Biomedicines, Inc. news
- Generate Biomedicines at guggenheim conference: speed over caution
Investing.com ·
- Top Generate Biomedicines (GENB) Competitors 2026
MarketBeat ·
- Generate CEO sees ‘huge opportunity’ from using Claude to shorten CAR-T cell engines
Fierce Biotech ·
- After selling 11,409 shares, Generate Biomedicines (GENB) director holds 220,063 directly.
Stock Titan ·
- Generate Biomedicines (GENB) Rises 4.84% to $13.85 as Shares Push Toward Upper Range - Gap and Go
https://www.dars.gov.et/ ·
- Generate Biomedicines (GENB) Stock Looks Fully Priced On Its 17% Jump
Yahoo Finance ·
- Anthropic Announced New Achievements in Drug Research and Lab Work. An Expert Says AI is 'Changing the Medical Field.'
ibtimes.com ·
- Generate Biomedicines to Participate in November Investor Conferences
Yahoo Finance ·
- Zealand Pharma pens $1.2bn AI obesity drug discovery pact with Generate
pharmaceutical-technology.com ·
- Generate Biomedicines Lands Major AI Drug Partnership to Target Booming Obesity Market
Yahoo Finance ·
- Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
Yahoo Finance ·
- Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
Yahoo Finance ·
Generate Biomedicines, Inc. key financials
| USD | 2025 |
|---|---|
| Total assets (year end) | $330.2M |
| Cash and equivalents (year end) | $121.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Generate Biomedicines, Inc.
- Ticker
- GENB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Somerville, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 2100782
Frequently asked questions
What exchange is Generate Biomedicines, Inc. listed on?
Generate Biomedicines, Inc. trades on the Nasdaq under the ticker symbol GENB.
What industry is Generate Biomedicines, Inc. in?
Generate Biomedicines, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Generate Biomedicines, Inc. headquartered?
Generate Biomedicines, Inc.'s business address on file with the SEC is in Somerville, MA.
When does Generate Biomedicines, Inc.'s fiscal year end?
Generate Biomedicines, Inc.'s fiscal year ends on December 31.